ArticleJournal of cancer research and clinical oncology2023
Adjuvant chemotherapy for pT1-3N0-1 breast cancer patients with HR+, HER2- subtype: a propensity-score matched study with competing risk analysis.
Hong Dong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.